指南与共识免疫规划卫生政策与健康促进

老年人呼吸道合胞病毒疫苗的使用:免疫实践咨询委员会的建议——美国,2023年

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
指南 / 共识 · MMWR Morb Mortal Wkly Rep · 2023-07-21

呼吸道合胞病毒(RSV)是老年人严重呼吸道疾病的病因。2023年5月,美国食品药品监督管理局批准首批用于预防≥60岁成人RSV相关下呼吸道疾病的疫苗。免疫实践咨询委员会(ACIP)于2023年6月21日投票建议≥60岁成人可接种单剂RSV疫苗,采用共享临床决策。本报告总结了支持该建议的证据并提供了临床指导。

要点

  • ACIP建议≥60岁成人可接种单剂RSV疫苗,采用共享临床决策。
  • RSV疫苗在预防RSV相关下呼吸道疾病方面显示中到高效力。
  • 上市后监测将指导未来指南。

核心结论

  • ACIP建议≥60岁成人可接种单剂RSV疫苗,采用共享临床决策。

研究设计与样本

  • ACIP RSV疫苗成人工作组自2022年5月起至少每月开会,审查≥60岁成人中这些疫苗的安全性、免疫原性和效力证据。

主要发现

  • RSV疫苗在预防RSV相关下呼吸道疾病方面显示中到高效力。
  • RSV疫苗有潜力预防老年人大量发病和死亡。

关键数值与推荐

  • 2023年6月21日,ACIP投票建议≥60岁成人可接种单剂RSV疫苗,采用共享临床决策。

临床怎么用

  • ≥60岁成人可接种单剂RSV疫苗,采用共享临床决策。

局限性

  • 上市后监测将指导未来指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory syncytial virus (RSV) is a cause of severe respiratory illness in older adults. In May 2023, the Food and Drug Administration approved the first vaccines for prevention of RSV-associated lower respiratory tract disease in adults aged ≥60 years. Since May 2022, the Advisory Committee on Immunization Practices (ACIP) Respiratory Syncytial Virus Vaccines Adult Work Group met at least monthly to review available evidence regarding the safety, immunogenicity, and efficacy of these vaccines among adults aged ≥60 years. On June 21, 2023, ACIP voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. This report summarizes the body of evidence considered for this recommendation and provides clinical guidance for the use of RSV vaccines in adults aged ≥60 years. RSV vaccines have demonstrated moderate to high efficacy in preventing RSV-associated lower respiratory tract disease and have the potential to prevent substantial morbidity and mortality among older adults; postmarketing surveillance will direct future guidance.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Melgar M, Britton A, Roper LE, et al. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37471262. doi:10.15585/mmwr.mm7229a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。